Increasing burden of institutional review in multicenter clinical trials of infertility

The Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies

William D. Schlaff, Heping Zhang, Michael Peter Diamond, Christos Coutifaris, Peter R. Casson, Robert G. Brzyski, Gregory M. Christman, Kurt T. Barnhart, J. C. Trussell, Stephen A. Krawetz, Peter J. Snyder, Dana Ohl, Nanette Santoro, Esther Eisenberg, Hao Huang, Richard S. Legro

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Many clinical investigators think that the burden of Institutional Review Board (IRB) requirements has been consistently increasing over recent years, although there are few objective data describing these trends. Over a period of 7 years, the Reproductive Medicine Network observed a significant increase in the size and requirements of IRB submissions and significant variability of IRB performance in reviewing multicenter trials. These additional regulatory and administrative demands represent substantial burdens to researchers and to the IRBs themselves. It is timely to consider whether these changes better protect the interests and safety of human research participants. Clinical trial registration: ClinicalTrials.gov NCT00068861 and NCT00719186.

Original languageEnglish (US)
Pages (from-to)15-18
Number of pages4
JournalFertility and sterility
Volume96
Issue number1
DOIs
StatePublished - Jan 1 2011
Externally publishedYes

Fingerprint

Reproductive Medicine
Polycystic Ovary Syndrome
Research Ethics Committees
Infertility
Multicenter Studies
Clinical Trials
Pregnancy
Research Personnel
Safety
Research

Keywords

  • Multicenter clinical trials
  • ethical review
  • human experimentation
  • institutional review boards

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Increasing burden of institutional review in multicenter clinical trials of infertility : The Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies. / Schlaff, William D.; Zhang, Heping; Diamond, Michael Peter; Coutifaris, Christos; Casson, Peter R.; Brzyski, Robert G.; Christman, Gregory M.; Barnhart, Kurt T.; Trussell, J. C.; Krawetz, Stephen A.; Snyder, Peter J.; Ohl, Dana; Santoro, Nanette; Eisenberg, Esther; Huang, Hao; Legro, Richard S.

In: Fertility and sterility, Vol. 96, No. 1, 01.01.2011, p. 15-18.

Research output: Contribution to journalArticle

Schlaff, WD, Zhang, H, Diamond, MP, Coutifaris, C, Casson, PR, Brzyski, RG, Christman, GM, Barnhart, KT, Trussell, JC, Krawetz, SA, Snyder, PJ, Ohl, D, Santoro, N, Eisenberg, E, Huang, H & Legro, RS 2011, 'Increasing burden of institutional review in multicenter clinical trials of infertility: The Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies', Fertility and sterility, vol. 96, no. 1, pp. 15-18. https://doi.org/10.1016/j.fertnstert.2011.05.069
Schlaff, William D. ; Zhang, Heping ; Diamond, Michael Peter ; Coutifaris, Christos ; Casson, Peter R. ; Brzyski, Robert G. ; Christman, Gregory M. ; Barnhart, Kurt T. ; Trussell, J. C. ; Krawetz, Stephen A. ; Snyder, Peter J. ; Ohl, Dana ; Santoro, Nanette ; Eisenberg, Esther ; Huang, Hao ; Legro, Richard S. / Increasing burden of institutional review in multicenter clinical trials of infertility : The Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies. In: Fertility and sterility. 2011 ; Vol. 96, No. 1. pp. 15-18.
@article{48c63b6e12af46f097df4d3c2d7c1ed7,
title = "Increasing burden of institutional review in multicenter clinical trials of infertility: The Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies",
abstract = "Many clinical investigators think that the burden of Institutional Review Board (IRB) requirements has been consistently increasing over recent years, although there are few objective data describing these trends. Over a period of 7 years, the Reproductive Medicine Network observed a significant increase in the size and requirements of IRB submissions and significant variability of IRB performance in reviewing multicenter trials. These additional regulatory and administrative demands represent substantial burdens to researchers and to the IRBs themselves. It is timely to consider whether these changes better protect the interests and safety of human research participants. Clinical trial registration: ClinicalTrials.gov NCT00068861 and NCT00719186.",
keywords = "Multicenter clinical trials, ethical review, human experimentation, institutional review boards",
author = "Schlaff, {William D.} and Heping Zhang and Diamond, {Michael Peter} and Christos Coutifaris and Casson, {Peter R.} and Brzyski, {Robert G.} and Christman, {Gregory M.} and Barnhart, {Kurt T.} and Trussell, {J. C.} and Krawetz, {Stephen A.} and Snyder, {Peter J.} and Dana Ohl and Nanette Santoro and Esther Eisenberg and Hao Huang and Legro, {Richard S.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1016/j.fertnstert.2011.05.069",
language = "English (US)",
volume = "96",
pages = "15--18",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Increasing burden of institutional review in multicenter clinical trials of infertility

T2 - The Reproductive Medicine Network experience with the Pregnancy in Polycystic Ovary Syndrome (PPCOS) I and II studies

AU - Schlaff, William D.

AU - Zhang, Heping

AU - Diamond, Michael Peter

AU - Coutifaris, Christos

AU - Casson, Peter R.

AU - Brzyski, Robert G.

AU - Christman, Gregory M.

AU - Barnhart, Kurt T.

AU - Trussell, J. C.

AU - Krawetz, Stephen A.

AU - Snyder, Peter J.

AU - Ohl, Dana

AU - Santoro, Nanette

AU - Eisenberg, Esther

AU - Huang, Hao

AU - Legro, Richard S.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Many clinical investigators think that the burden of Institutional Review Board (IRB) requirements has been consistently increasing over recent years, although there are few objective data describing these trends. Over a period of 7 years, the Reproductive Medicine Network observed a significant increase in the size and requirements of IRB submissions and significant variability of IRB performance in reviewing multicenter trials. These additional regulatory and administrative demands represent substantial burdens to researchers and to the IRBs themselves. It is timely to consider whether these changes better protect the interests and safety of human research participants. Clinical trial registration: ClinicalTrials.gov NCT00068861 and NCT00719186.

AB - Many clinical investigators think that the burden of Institutional Review Board (IRB) requirements has been consistently increasing over recent years, although there are few objective data describing these trends. Over a period of 7 years, the Reproductive Medicine Network observed a significant increase in the size and requirements of IRB submissions and significant variability of IRB performance in reviewing multicenter trials. These additional regulatory and administrative demands represent substantial burdens to researchers and to the IRBs themselves. It is timely to consider whether these changes better protect the interests and safety of human research participants. Clinical trial registration: ClinicalTrials.gov NCT00068861 and NCT00719186.

KW - Multicenter clinical trials

KW - ethical review

KW - human experimentation

KW - institutional review boards

UR - http://www.scopus.com/inward/record.url?scp=79959869555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959869555&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2011.05.069

DO - 10.1016/j.fertnstert.2011.05.069

M3 - Article

VL - 96

SP - 15

EP - 18

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 1

ER -